Platelets in lung biology

Annual Review of Physiology

Volumn 75, Issue , 2013, Pages 569-591

  Weyrich, Andrew S ^a   Zimmerman, Guy A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; ALI; Alveolus; ARDS; Barrier function; Endothelial cells; Hemorrhage; Inflammation; Megakaryocytes; Permeability; Thrombopoiesis

Indexed keywords

ADENOSINE; ADRENALIN; ALPHA2 INTEGRIN; ANGIOPOIETIN 1; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; SEROTONIN; SPHINGOSINE 1 PHOSPHATE; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN;

ADULT RESPIRATORY DISTRESS SYNDROME; CELL FATE; CELL INTERACTION; CELL MATURATION; HUMAN; LUNG BIOPSY; LUNG BLOOD VESSEL; LUNG DISEASE; LUNG ENDOTHELIUM; LUNG FUNCTION; MEGAKARYOCYTE; NONHUMAN; OSTEOARTHROPATHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY SHUNT; REVIEW; STEM CELL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ANIMALS; BLOOD PLATELETS; BLOOD-AIR BARRIER; HOMEOSTASIS; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES;

EID: 84873681788     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-030212-183752     Document Type: Review

References (139)

1. Michelson AD, ed. 2013. Platelets. San Diego: Elsevier/Academic. 3rd ed. In press
2. Bierman HR. 1955. The hematologic role of the lung in man. Am. J. Surg. 89:130-40
3. Heffner JE, Repine JE. 1991. Platelets. In The Lung: Scientific Foundations, ed. RG Crystal, pp. 617-30. New York: Raven
4. Herd CM, Page CP. 1994. Pulmonary immune cells in health and disease: platelets. Eur. Respir. J. 7:1145-60
5. Heffner JE, Repine JE. 1997. Platelets. In The Lung: Scientific Foundations, ed. RG Crystal, pp. 947-59. New York: Raven. 2nd ed.
6. Tabuchi A, Kuebler WM. 2008. Endothelium-platelet interactions in inflammatory lung disease. Vascul. Pharmacol. 49:141-50
7. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. 2009. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am. J. Respir. Cell Mol. Biol. 40:123-34
8. Zarbock A, Ley K. 2009. The role of platelets in acute lung injury (ALI). Front. Biosci. 14:150-58
9. Voelkel NF, Rounds S, eds. The Pulmonary Endothelium: Function in Health and Disease. New York: Wiley & Sons
10. Nicolls MR, Tamosiuniene T, Babu AN, Voelkel NF. 2009. Interactions of pulmonary endothelial cells with immune cells and platelets: implications for disease pathogenesis. See Ref. 9, pp. 417-36
11. Rodrigues RS, Zimmerman GA. 2009. Pulmonary endothelial interactions with leukocytes and platelets. See Ref. 9, pp. 146-66
12. Vieira-de-Abreu A, Rondina MT, Weyrich AS, Zimmerman GA. 2013. Inflammation. See Ref. 1. In press
13. Weyrich AS, Zimmerman GA. 2004. Platelets: signaling cells in the immune continuum. Trends Immunol. 25:489-95
14. Semple JW, Italiano JE Jr, Freedman J. 2011. Platelets and the immune continuum. Nat. Rev. Immunol. 11:264-74
15. Vieira-de-Abreu A, Campbell RA, Weyrich AS, Zimmerman GA. 2012. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin. Immunopathol. 34:5-30
16. Zimmerman GA, Weyrich AS. 2008. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler. Thromb. Vasc. Biol. 28:S17-24
17. Provost P. 2013. Platelet microRNA. See Ref. 1. In press
18. Weyrich AS. 2013. Platelet proteomics. See Ref. 1. In press
19. Ouwehand W, Bray PF. 2013. Platelet genomics. See Ref. 1. In press
20. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, et al. 2011. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118:e101-11
21. Kahr WH, Hinckley J, Li L, Schwertz H, Christensen H, et al. 2011. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat. Genet. 43:738-40
22. Schwertz H, Koster S, Kahr WH, Michetti N, Kraemer BF, et al. 2010. Anucleate platelets generate progeny. Blood 115:3801-9
23. Thon JN, Montalvo A, Patel-Hett S, Devine MT, Richardson JL, et al. 2010. Cytoskeletal mechanics of proplatelet maturation and platelet release. J. Cell Biol. 191:861-74
24. Italiano JE, Hartwig JH. 2013. Megakaryocyte development and platelet formation. See Ref. 1. In press
25. Dunois-Larde C, Capron C, Fichelson S, Bauer T, Cramer-Borde E, Baruch D. 2009. Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 114:1875-83
26. Junt T, Schulze H, Chen Z, Massberg S, Goerge T, et al. 2007. Dynamic visualization of thrombopoiesis within bone marrow. Science 317:1767-70
27. Howell WH, Donahue DD. 1937. The production of blood platelets in the lungs. J. Exp. Med. 65:177-203
28. Jordan HE. 1940. The origin and significance of the megakaryocytes of the lung. Anat. Rec. 77:99-101
29. Pedersen NT. 1974. The pulmonary vessels as a filter for circulating megakaryocytes in rats. Scand. J. Haematol. 13:225-31
30. Davis RE, Stenberg PE, Levin J, Beckstead JH. 1997. Localization of megakaryocytes in normal mice and following administration of platelet antiserum, 5-fluorouracil, or radiostrontium: evidence for the site of platelet production. Exp. Hematol. 25:638-48
31. Zucker-Franklin D, Philipp CS. 2000. Platelet production in the pulmonary capillary bed: new ultra-structural evidence for an old concept. Am. J. Pathol. 157:69-74
32. Thon JN, Italiano JE. 2010. Platelet formation. Semin. Hematol. 47:220-26
33. Mandal RV, Mark EJ, Kradin RL. 2007. Megakaryocytes and platelet homeostasis in diffuse alveolar damage. Exp. Mol. Pathol. 83:327-31
34. Scheinin TM, Koivuniemi AP. 1963. Megakaryocytes in the pulmonary circulation. Blood 22:82-87
35. Kaufman RM, Airo R, Pollack S, Crosby WH. 1965. Circulating megakaryocytes and platelet release in the lung. Blood 26:720-31
36. Melamed MR, Cliffton EE, Mercer C, Koss LG. 1966. The megakaryocyte blood count. Am. J. Med. Sci. 252:301-9
37. Pedersen NT. 1978. Occurrence of megakaryocytes in various vessels and their retention in the pulmonary capillaries in man. Scand. J. Haematol. 21:369-75
38. Kallinikos-Maniatis A. 1969. Megakaryocytes and platelets in central venous and arterial blood. Acta Haematol. 42:330-35
39. Levine RF, Eldor A, Shoff PK, Kirwin S, Tenza D, Cramer EM. 1993. Circulating megakaryocytes: delivery of large numbers of intact, mature megakaryocytes to the lungs. Eur. J. Haematol. 51:233-46
40. Hansen M, Pedersen NT. 1979. Circulating megakaryocytes in patients with pulmonary inflammation and in patients subjected to cholecystectomy. Scand. J. Haematol. 23:211-16
41. Trowbridge EA. 1988. Pulmonary platelet production: a physical analogue of mitosis? Blood Cells 13:451-65
42. Kaufman RM, Airo R, Pollack S, Crosby WH, Doberneck R. 1965. Origin of pulmonary megakaryocytes. Blood 25:767-75
43. Wilde NT, Burgess R, Keenan DJ, Lucas GS. 1997. The effect of cardiopulmonary bypass on circulating megakaryocytes. Br. J. Haematol. 98:322-27
44. Avraham H, Cowley S, Chi SY, Jiang S, Groopman JE. 1993. Characterization of adhesive interactions between human endothelial cells and megakaryocytes. J. Clin. Investig. 91:2378-84
45. George JN. 2000. Platelets. Lancet 355:1531-39
46. Sharnoff JG, Scardino V. 1960. Platelet-count differences in blood of the rabbit right and left heart ventricles. Nature 187:334-35
47. Warheit DB, Barnhart MI. 1981. Ultrastructure of circulating and platelet-forming megakaryocytes: a combined correlative SEM-TEM and SEM histochemical study. Ann. N. Y. Acad. Sci. 370:30-41
48. Trowbridge EA, Martin JF, Slater DN. 1982. Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation. Thromb. Res. 28:461-75
49. Fuentes R, Wang Y, Hirsch J, Wang C, Rauova L, et al. 2010. Infusion of mature megakaryocytes into mice yields functional platelets. J. Clin. Investig. 120:3917-22
50. Leavitt AD. 2010. Are there more tricks in the bag for treating thrombocytopenia? J. Clin. Investig. 120:3807-10
51. Behnke O, Forer A. 1998. From megakaryocytes to platelets: Platelet morphogenesis takes place in the bloodstream. Eur. J. Haematol. Suppl. 61:3-23
52. Schwertz H, Weyrich AS. 2010. Platelet precursors display bipolar behavior. J. Cell Biol. 191:699-700
53. Handagama PJ, Feldman BF, Jain NC, Farver TB, Kono CS. 1987. Circulating proplatelets: isolation and quantitation in healthy rats and in rats with induced acute blood loss. Am. J. Vet. Res. 48:962-65
54. Doerschuk CM, Downey GP, Doherty DE, English D, Gie RP, et al. 1990. Leukocyte and platelet margination within microvasculature of rabbit lungs. J. Appl. Physiol. 68:1956-61
55. Bierman HR, Kelly KH, King FW, Petrakis NL. 1951. The pulmonary circulation as a source of leucocytes and platelets in man. Science 114:276-77
56. Bierman HR, Kelly KH, Cordes FL, Byron RL Jr, Polhemus JA, Rappoport S. 1952. The release of leukocytes and platelets from the pulmonary circulation by epinephrine. Blood 7:683-92
57. Markos J, Hooper RO, Kavanagh-Gray D, Wiggs BR, Hogg JC. 1990. Effect of raised alveolar pressure on leukocyte retention in the human lung. J. Appl. Physiol. 69:214-21
58. Tabuchi A, Mertens M, Kuppe H, Pries AR, Kuebler WM. 2008. Intravital microscopy of the murine pulmonary microcirculation. J. Appl. Physiol. 104:338-46
59. Eichhorn ME, Ney L, Massberg S, Goetz AE. 2002. Platelet kinetics in the pulmonary microcirculation in vivo assessed by intravital microscopy. J. Vasc. Res. 39:330-39
60. Kien M, Hechtman H, Shepro D. 1971. Platelet-microvasculature interaction during one passage through the dog lung. Microvasc. Res. 3:209-10
61. Bachofen M, Weibel ER. 1982. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med. 3:35-56
62. Shattil SJ, Kim C, Ginsberg MH. 2010. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 11:288-300
63. Jean-Baptiste E. 2000. Clinical assessment and management of massive hemoptysis. Crit. Care Med. 28:1642-47
64. Ho-Tin-Noe B, Demers M, Wagner DD. 2011. How platelets safeguard vascular integrity. J. Thromb. Haemost. 9(Suppl. 1):56-65
65. Lo SK, Burhop KE, Kaplan JE, Malik AB. 1988. Role of platelets in maintenance of pulmonary vascular permeability to protein. Am. J. Physiol. Heart Circ. Physiol. 254:H763-71
66. Staub NC. 1978. Pulmonary edema: physiologic approaches to management. Chest 74:559-64
67. Ware LB, Matthay MA. 2005. Clinical practice. Acute pulmonary edema. N. Engl. J. Med. 353:2788-96
68. Pearse DB, Brower RG, Adkinson NF Jr, Sylvester JT. 1989. Spontaneous injury in isolated sheep lungs: role of perfusate leukocytes and platelets. J. Appl. Physiol. 66:1287-96
69. Heffner JE, Cook JA, Halushka PV. 1989. Human platelets modulate edema formation in isolated rabbit lungs. J. Clin. Investig. 84:757-64
70. Zamora CA, Baron D, Heffner JE. 1991. Washed human platelets prevent ischemia-reperfusion edema in isolated rabbit lungs. J. Appl. Physiol. 70:1075-84
71. Nachman RL, Rafii S. 2008. Platelets, petechiae, and preservation of the vascular wall. N. Engl. J. Med. 359:1261-70
72. Roy AJ, Djerassi I. 1972. Effects of platelet transfusions: plug formation and maintenance of vascular integrity. Proc. Soc. Exp. Biol. Med. 139:137-42
73. Kitchens CS, Pendergast JF. 1986. Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration. Blood 67:203-6
74. Goerge T, Ho-Tin-Noe B, Carbo C, Benarafa C, Remold-O'Donnell E, et al. 2008. Inflammation induces hemorrhage in thrombocytopenia. Blood 111:4958-64
75. Jackson DP, Sorensen DK, Cronkite EP, Bond VP, Fliedner TM. 1959. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J. Clin. Investig. 38:1689-97
76. Maguire PB, Belton O, O'Donoghue N, Austini S. 2007. Platelet-endothelial interactions. In Endothelial Biomedicine, ed. WC Aird, pp. 597-601. Cambridge, UK: Cambridge Univ. Press
77. Majno G, Palade GE. 1961. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J. Biophys. Biochem. Cytol. 11:571-605
78. Lee HZ, Lin WC, Yeh FT, Wu CH. 1998. 2-Phenyl-4-quinolone prevents serotonin-induced increases in endothelial permeability to albumin. Eur. J. Pharmacol. 354:205-13
79. Zhao D, Qin L, Bourbon PM, James L, Dvorak HF, Zeng H. 2011. Orphan nuclear transcription factor TR3/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctions. Proc. Natl. Acad. Sci. USA 108:12066-71
80. Obinata H, Hla T. 2012. Sphingosine 1-phosphate in coagulation and inflammation. Semin. Immunopathol. 34:73-91
81. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, et al. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99:301-12
82. Vestweber D, Winderlich M, Cagna G, Nottebaum AF. 2009. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 19:8-15
83. Matthay MA, Ware LB, Zimmerman GA. 2012. The acute respiratory distress syndrome. J. Clin. Investig. 122:2731-40
84. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, et al. 2001. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Investig. 108:689-701
85. Schaphorst KL, Chiang E, Jacobs KN, Zaiman A, Natarajan V, et al. 2003. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L258-67
86. Wolfson RK, Lang G, Jacobson J, Garcia JGN. 2009. Therapeutic strategies to limit lung endothelial cell permeability. See Ref. 9, pp. 337-54
87. Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, et al. 2009. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Investig. 119:1871-79
88. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, et al. 2004. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit. Care Med. 169:1245-51
89. Tauseef M, Kini V, Knezevic N, Brannan M, Ramchandaran R, et al. 2008. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ. Res. 103:1164-72
90. Sammani S, Moreno-Vinasco L, Mirzapoiazova T, Singleton PA, Chiang ET, et al. 2010. Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. Am. J. Respir. Cell Mol. Biol. 43:394-402
91. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, et al. 2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146:980-91
92. Shea BS, Brooks SF, Fontaine BA, Chun J, Luster AD, Tager AM. 2010. Prolonged exposure to sphingo-sine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am. J. Respir. Cell Mol. Biol. 43:662-73
93. Li X, Stankovic M, Bonder CS, Hahn CN, Parsons M, et al. 2008. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood 111:3489-97
94. Braunstein PW, Cuenoud HF, Joris I, Majno G. 1980. Platelets, fibroblasts, and inflammation: tissue reactions to platelets injected subcutaneously. Am. J. Pathol. 99:53-66
95. Kim MH, Curry FR, Simon SI. 2009. Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am. J. Physiol. Cell Physiol. 296:C848-56
96. Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, et al. 2008. Angiogenesisisregulated by a novel mechanism: Pro-and antiangiogenic proteins are organized into separate platelet αgranules and differentially released. Blood 111:1227-33
97. Raghavachari N, Xu X, Harris A, Villagra J, Logun C, et al. 2007. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 115:1551-62
98. Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, et al. 2011. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J. Thromb. Haemost. 9:748-58
99. Sato K, Webb S, Tucker A, Rabinovitch M, O'Brien RF, et al. 1992. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am. Rev. Respir. Dis. 145:793-97
100. Peacock AJ, Egermayer P, Town GI. 2002. The role of platelets in pulmonary hypertension. In Interactions of Blood and the Pulmonary Circulation, ed. EK Weir, HL Reeve, JT Reeves, pp. 187-201. New York: Futura
101. McGoon MD, Vanhoutte PM. 1984. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. J. Clin. Investig. 74:828-33
102. Ciuclan L, Bonneau O, Hussey M, Duggan N, Holmes AM, et al. 2011. A novel murine model of severe pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 184:1171-82
103. Harris ES, Rondina MT, Schwertz H, Weyrich AS, Zimmerman GA. 2010. Pathogenesis of sepsis and sepsis-induced acute lung injury. In Acute Respiratory Distress Syndrome, ed. AMK Choi, pp. 369-419. New York: Informa Healthcare. 2nd ed.
104. Heffner JE, Shoemaker SA, Canham EM, Patel M, McMurtry IF, et al. 1983. Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2. J. Clin. Investig. 71:351-57
105. Snapper JR, Hinson JM Jr, Hutchison AA, Lefferts PL, Ogletree ML, Brigham KL. 1984. Effects of platelet depletion on the unanesthetized sheep's pulmonary response to endotoxemia. J. Clin. Investig. 74:1782-91
106. Vanhoutte PM, Houston DS. 1985. Platelets, endothelium, and vasospasm. Circulation 72:728-34
107. Nurden AT. 2011. Platelets, inflammation and tissue regeneration. Thromb. Haemost. 105(Suppl. 1):13-33
108. de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, et al. 2006. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler. Thromb. Vasc. Biol. 26:1653-59
109. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, et al. 2006. Platelets secrete stromal cell-derived factor 1α and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J. Exp. Med. 203:1221-33
110. + cells to endothelial progenitor cells. Circulation 117:206-15
111. Stellos K, Gnerlich S, Kraemer B, Lindemann S, Gawaz M. 2008. Platelet interaction with progenitor cells: vascular regeneration or inquiry? Pharmacol. Rep. 60:101-8
112. + hemangiocytes. Nat. Med. 12:557-67
113. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, et al. 1996. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Investig. 97:1525-34
114. Dixon DA, Tolley ND, Bemis-Standoli K, Martinez ML, Weyrich AS, et al. 2006. Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J. Clin. Investig. 116:2727-38
115. Shi Q, Wilcox DA, Fahs SA, Weiler H, Wells CW, et al. 2006. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. J. Clin. Investig. 116:1974-82
116. Barst RJ. 2005. PDGF signaling in pulmonary arterial hypertension. J. Clin. Investig. 115:2691-94
117. Tuder RM, Erzurum SC. 2009. Pulmonary endothelium and pulmonary hypertension. See Ref. 9, pp. 449-60
118. Eddahibi S, Guignabert C, Barlier-Mur AM, Dewachter L, Fadel E, et al. 2006. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation 113:1857-64
119. Lang IM. 2009. Pulmonary endothelium in thromboembolism. See Ref. 9, pp. 471-83
120. Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, et al. 2011. Platelet-derived serotonin links vascular disease and tissue fibrosis. J. Exp. Med. 208:961-72
121. Fabre A, Marchal-Somme J, Marchand-Adam S, Quesnel C, Borie R, et al. 2008. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. Eur. Respir. J. 32:426-36
122. Rondina MT, Brewster B, Grissom CK, Zimmerman GA, Kastendieck DH, et al. 2012. In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest 141:1490-95.
123. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. 2006. Neutrophils and their Fcγ receptors are essential in a mouse model of transfusion-related acute lung injury. J. Clin. Investig. 116:1615-23
124. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. 2009. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J. Clin. Investig. 119:3450-61
125. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, et al. 2012. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Investig. 122:2661-71
126. Davi G, Iapichino L, Balsamo V, Ganci A, Giammarresi C, et al. 1995. Thromboxane biosynthesis and pulmonary function in cystic fibrosis. Adv. Prostaglandin Thromboxane Leukot. Res. 23:369-71
127. Pitchford SC, Yano H, Lever R, Riffo-Vasquez Y, Ciferri S, et al. 2003. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112:109-18
128. O'Sullivan BP, Michelson AD. 2006. The inflammatory role of platelets in cystic fibrosis. Am. J. Respir Crit. Care Med. 173:483-90
129. Pitchford SC, Momi S, Baglioni S, Casali L, Giannini S, et al. 2008. Allergen induces the migration of platelets to lung tissue in allergic asthma. Am. J. Respir. Crit. Care Med. 177:604-12
130. Johansson MW, Han ST, Gunderson KA, Busse WW, Jarjour NN, Mosher DF. 2012. Platelet activation, P-selectin, and eosinophil β31-integrin activation in asthma. Am. J. Respir. Crit. Care Med. 185:498-507
131. Tammela T, Alitalo K. 2010. Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460-76
132. Murciano JC, Harshaw D, Neschis DG, Koniaris L, Bdeir K, et al. 2002. Platelets inhibit the lysis of pulmonary microemboli. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L529-39
133. von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, et al. 2012. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209:819-35
134. Gay LJ, Felding-Habermann B. 2011. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 11:123-34
135. Lonsdorf AS, Kramer BF, Fahrleitner M, Schonberger T, Gnerlich S, et al. 2012. Engagement of cxIIbβ33 (GPIIb/IIIa) with ocvβ33 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. J. Biol. Chem. 287:2168-78
136. Yiming MT, Lederer DJ, Sun L, Huertas A, Issekutz AC, Bhattacharya S. 2008. Platelets enhance endothelial adhesiveness in high tidal volume ventilation. Am. J. Respir. Cell Mol. Biol. 39:569-75
137. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, et al. 2005. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122:379-91
138. Weyrich AS, Denis MM, Schwertz H, Tolley ND, Foulks J, et al. 2007. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood 109:1975-83
139. Hogg JC, Doerschuk CM. 1995. Leukocyte traffic in the lung. Annu. Rev. Physiol. 57:97-114